NASDAQ: SGPSpyglass Pharma Inc Stock Ownership - Who owns Spyglass Pharma?
Insider buying vs selling
Have Spyglass Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Forest Baskett | 10% Owner | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| Ali Behbahani | Director | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| Carmen Chang | 10% Owner | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| Anthony A. Florence Jr. | 10% Owner | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| Bilal Arshad Khan | Director | 2026-02-09 | 20,000 | $16.00 | $320.00kBuy |
| Bilal Arshad Khan | Director | 2026-02-09 | 115,000 | $16.00 | $1.84MBuy |
| Mohamad Makhzoumi | 10% Owner | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| Edward T. Mathers | 10% Owner | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| New Enterprise Associates 17 LP | 10% Owner | 2026-02-09 | 937,500 | $16.00 | $15.00MBuy |
| Kirk G. Nielsen | Director | 2026-02-09 | 165,000 | $16.00 | $2.64MBuy |
SGP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SGP insiders and whales buy or sell their stock.
SGP Shareholders
What type of owners hold Spyglass Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 23.99% | 8,021,117 | $169.89M | Institution |
| Paul Edward Walker | 22.11% | 7,392,301 | $156.57M | Insider |
| Carmen Chang | 22.11% | 7,392,301 | $156.57M | Insider |
| Anthony A. Florence Jr. | 22.11% | 7,392,301 | $156.57M | Insider |
| Mohamad Makhzoumi | 22.11% | 7,392,301 | $156.57M | Insider |
| Forest Baskett | 22.11% | 7,392,301 | $156.57M | Insider |
| Ali Behbahani | 22.11% | 7,392,301 | $156.57M | Insider |
| Nea Management Company LLC | 22.11% | 7,392,301 | $156.57M | Institution |
| Scott D. Sandell | 22.11% | 7,392,301 | $156.57M | Insider |
| Edward T. Mathers | 18.05% | 6,035,038 | $127.82M | Insider |
SGP vs Biotech Stocks
Spyglass Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.